615 related articles for article (PubMed ID: 15269137)
21. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping.
Xue Y; Zhou Y; Wu T; Zhu T; Ji X; Kwon YS; Zhang C; Yeo G; Black DL; Sun H; Fu XD; Zhang Y
Mol Cell; 2009 Dec; 36(6):996-1006. PubMed ID: 20064465
[TBL] [Abstract][Full Text] [Related]
23. Cloning and expression of ligand-gated ion-channel receptor L2 in central nervous system.
Houtani T; Munemoto Y; Kase M; Sakuma S; Tsutsumi T; Sugimoto T
Biochem Biophys Res Commun; 2005 Sep; 335(2):277-85. PubMed ID: 16083862
[TBL] [Abstract][Full Text] [Related]
24. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition.
Izquierdo JM; Majós N; Bonnal S; Martínez C; Castelo R; Guigó R; Bilbao D; Valcárcel J
Mol Cell; 2005 Aug; 19(4):475-84. PubMed ID: 16109372
[TBL] [Abstract][Full Text] [Related]
25. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
Guo J; Jia J; Jia R
Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
[TBL] [Abstract][Full Text] [Related]
26. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay.
Wollerton MC; Gooding C; Wagner EJ; Garcia-Blanco MA; Smith CW
Mol Cell; 2004 Jan; 13(1):91-100. PubMed ID: 14731397
[TBL] [Abstract][Full Text] [Related]
27. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing of the sheep MITF gene: novel transcripts detectable in skin.
Saravanaperumal SA; Pediconi D; Renieri C; La Terza A
Gene; 2014 Nov; 552(1):165-75. PubMed ID: 25239663
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.
He X; Pool M; Darcy KM; Lim SB; Auersperg N; Coon JS; Beck WT
Oncogene; 2007 Jul; 26(34):4961-8. PubMed ID: 17310993
[TBL] [Abstract][Full Text] [Related]
30. Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs.
Omori F; Juopperi T; Chan CK; Chang YN; Phipps S; Nanji S; Zhao Y; Stewart AK; Dubé ID
J Hematother Stem Cell Res; 1999 Oct; 8(5):503-14. PubMed ID: 10791901
[TBL] [Abstract][Full Text] [Related]
31. RON alternative splicing regulation in primary ovarian cancer.
Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.
Tada Y; Wada M; Migita T; Nagayama J; Hinoshita E; Mochida Y; Maehara Y; Tsuneyoshi M; Kuwano M; Naito S
Int J Cancer; 2002 Apr; 98(4):630-5. PubMed ID: 11920626
[TBL] [Abstract][Full Text] [Related]
33. RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20.
de la Mata M; Kornblihtt AR
Nat Struct Mol Biol; 2006 Nov; 13(11):973-80. PubMed ID: 17028590
[TBL] [Abstract][Full Text] [Related]
34. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
[TBL] [Abstract][Full Text] [Related]
35. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB.
Llorian M; Schwartz S; Clark TA; Hollander D; Tan LY; Spellman R; Gordon A; Schweitzer AC; de la Grange P; Ast G; Smith CW
Nat Struct Mol Biol; 2010 Sep; 17(9):1114-23. PubMed ID: 20711188
[TBL] [Abstract][Full Text] [Related]
36. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
He X; Zhang P
Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
[TBL] [Abstract][Full Text] [Related]
37. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon.
Lou H; Helfman DM; Gagel RF; Berget SM
Mol Cell Biol; 1999 Jan; 19(1):78-85. PubMed ID: 9858533
[TBL] [Abstract][Full Text] [Related]
38. In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1.
Rajagopal A; Pant AC; Simon SM; Chen Y
Cancer Res; 2002 Jan; 62(2):391-6. PubMed ID: 11809686
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines.
Marques DS; Grativol J; Alves da Silva Peres R; da Rocha Matos A; Gimba ERP
Tumour Biol; 2017 Sep; 39(9):1010428317725442. PubMed ID: 28936921
[TBL] [Abstract][Full Text] [Related]
40. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
Watermann DO; Tang Y; Zur Hausen A; Jäger M; Stamm S; Stickeler E
Cancer Res; 2006 May; 66(9):4774-80. PubMed ID: 16651431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
